Per-Oluf Olsen

Chief executive officer

Per-Oluf Olsen (born 1956) joined the company as chief executive officer in November 2008. Previously, Mr Olsen was regional executive director for central and eastern European region (CEER) at Pfizer. He holds extensive international experience in sales, marketing and management. During his 27 years with Pfizer he held numerous national and international positions, including country manager at Pfizer Italia SrL, country manager at Pfizer Norway and Denmark and pharmaceutical division manager at Pfizer A/S. Mr Olsen holds a degree in biochemistry from University of Oslo and a degree in marketing from Norwegian school of Marketing. Mr Olsen is a Norwegian citizen.

Morten Jurs

Chief financial officer

Morten Jurs (born 1960) has been chief financial officer of Pronova BioPharma since 2006. From 2002 to 2006, he was chief financial officer at Kitron ASA. Previous positions include CFO of Telenor Nextra and of Santech Micro Group ASA. Mr Jurs holds an MBA from the University of Wyoming. He held 459 375 shares in the company at 31 December 2007, and has no stock options. He is a Norwegian citizen.

Else-Marie Haram

Vice president
quality assurance

Else-Marie Haram (born 1947) joined Pronova BioPharma in 2004 and is vice president quality assurance. Previously, she was with Alpharma for 25 years, holding various positions in research and development, quality control and quality assurance and serving from 1994 to 2001 as vice president quality affairs for the international pharmaceuticals division. Ms Haram has an MSc from the Institute of Pharmacy at the University of Oslo. She held 216 298 shares in the company at 31 December 2007, and has no stock options. Ms Haram is a Norwegian citizen.

Hans Ivar Robinson

Vice president
pharmaceuticals and business development

Hans Ivar Robinson (born 1967) has been vice president commercial and business development at Pronova BioPharma since 2006. Previously, he held various positions at AstraZeneca in Oslo, London and Brussels. From 2005 to 2006, Mr Robinson was employed in Brussels and London as regional business director, Europe, Area 1. Before that, he led the sales and marketing organisation in the Norwegian marketing company for six years. Before joining AstraZeneca, Mr Robinson gained international experience at Pfizer International in New York. He holds an MSc in business from the Norwegian School of Economics and Business Administration, and has completed executive management courses at Insead and IMD. Mr Robinson held 553 250 shares in the company at 31 December 2007, and has no stock options. He is a Norwegian citizen.

Solveig Hellebust

Vice president
human resources and communications

Solveig Hellebust (born 1967) joined Pronova BioPharma in 2004 and is vice president human resources and communications. Previously, she was director for compensation and benefits at Telenor ASA. From 1998 to 2001, she worked as an associate professor in economics at the Norwegian School of Management. Dr Hellebust holds key qualifications as a specialist in compensation and benefits, and is a specialist in the field of corporate governance and corporate social responsibility. She holds a PhD in economics from the Norwegian University of Life Sciences, an MSc in agricultural economics from the University of Illinois, and an MSc in business and economics from the Norwegian School of Management. Dr Hellebust held 801 500 shares in the company at 31 December 2007, and has no stock options. She is a Norwegian citizen.

Kjetil Olsen

Vice president manufacturing development

Kjetil Olsen (1960) has been vice president manufacturing development at Pronova BioPharma since 2006 and from 2007 he holds the additional responsibility as managing director for Pronova BioPharma Denmark A/S. From 2001 - 06 he was vice president supply chain. Previously, he was purchasing director at Hydro Porsgrunn Industrial Park. He has also held positions in business process improvement projects at Hydro Agri Europe. Mr Olsen was located in Brussels for two and a half years as part of the project management team during the SAP implementation. He has previous experience as plant manager at Hydro Agri Porsgrunn (calcium nitrate/formic acids) and Hydro Magnesium Norway (magnesium chloride dehydration). Mr Olsen holds an MSc in process engineering from the Norwegian University of Science and Technology. He held 801 500 shares in the company at 31 December 2007, and has no stock options. Mr Olsen is a Norwegian citizen.

Cecilia Orheim

Vice President Legal Affairs

Cecilia Orheim (born 1972) has been head of legal affairs for Pronova BioPharma since 2004. Prior to joining the group, she was senior claim consultant at Claims Management Group Ltd. She has also worked as legal advisor for several Norwegian companies, including Tele2 Norge AS. From 1999 to 2000, Ms Orheim worked as a legal advisor at the Norwegian Ministry of Health and Social Affairs. She holds an LL M from the University of Oslo. Ms Orheim held 36 000 shares in the company at 31 December 2007, and has no stock options. She is a Norwegian citizen.

Hilde Steineger

Head of investor relations (IR)

Hilde Steineger (born 1966) has been head of IR at Pronova BioPharma since 2007. Before that, she was a senior associate at NeoMed Management from 2006 to 2007, business development consultant at Maxfield/Amino from 2003 to 2006 and senior financial analyst at Nordea Securities from 2001 to 2003. She received a PhD in medical biochemistry from the University of Oslo in 2000. Dr Steineger held 10 500 shares in the company at 31 December 2007, and has no stock options. She is a Norwegian citizen.

Trygve Christophersen

Vice president manufacturing

Trygve Christophersen (born 1959) has been vice president manufacturing of Pronova BioPharma since 2006. Previously, he was CEO of Grans Brewery in Sandefjord. Mr Christophersen has gained extensive experience from various executive positions in manufacturing companies
such as Ringnes AS and Mikron Tunsberg AS. He holds a business degree from the Norwegian School of Management and an MSc in engineering from the Norwegian University of Science and Technology. Mr Christophersen held 328 125 shares in the company at 31 December 2007, and has no stock options. He is a Norwegian citizen.

Gina Galligani

Senior director regulatory affairs

Gina Galligani (born 1956) joined Pronova BioPharma in 2005 and is senior manager regulatory affairs. She was previously with Pharmaq AS as head of regulatory affairs. Before that, she spent 20 years with Alpharma, holding various positions in regulatory affairs and serving as head of regulatory affairs for aquatic products from 1998 to 2004. Ms Galligani holds an MSc from the Institute of Pharmacy at the University of Oslo. She held 4 000 shares in the company at 31 December 2007, and has no stock options. Ms Galligani is a Norwegian citizen.